- Fraser Tennant
- Jul 22, 2015
- 5651 Views
The Medicines and Healthcare products Regulatory Agency (MHRA) can do more to place the UK at the forefront of a global drive to improve public health, according to a new report.
That’s the view of a new ‘Triennial Review’ of the agency which was tasked with investigating whether it remains fit for purpose and continues to deliver value for money for the UK taxpayer.
“There are some interesting challenges ahead, both domestically and globally, but the review has validated that we are well prepared to enthusiastically tackle them head on”, said MHRA chief executive Dr Ian Hudson.“Indeed, as the review highlights, we have already identified many of the areas where we can work smarter and strive for greater collaboration and efficiency, and we are already actively seeking improvements through our 2015/16 Business Plan.
“On behalf of all those who work in the agency, I strongly welcome the clear endorsement in the review of the agency’s fitness for purpose for the critical public health work that we do.”
The Triennial Review took place between November 2014 and May 2015 and was led by a small designated team within the Department of Health team working under the direction of an independent sponsor and project board.